McCabe: Comey’s Draft Statement Exonerating Clinton < >

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
134
McCabe: Comey’s Draft Statement Exonerating Clinton < >
Two Months before Her FBI Interview Was Not Normal Protocol

WASHINGTON — “This is the only time I am aware of, sir.” “I have not seen that before, sir.” “I’ve never seen that.”

These are just some of the words utilized by former acting FBI director Andrew McCabe when asked during closed door testimony about an email penned by disgraced ex-FBI chief James Comey circulating a draft statement exonerating Hillary Clinton in the private email server case a full two months before the FBI interviewed Clinton and other witnesses in the criminal probe.

Documents previously released by the FBI show that Comey on May 2, 2016 sent the email in question to McCabe, FBI general counsel James Baker and chief of staff and senior counselor James Rybicki. Clinton was interviewed by the FBI on June 2, with Comey later testifying that she was not sworn in and that the interview was not recorded.

Two months before Clinton’s FBI interview, Comey circulated the draft statement testing language to be used for not recommending charges against Clinton.

Former Rep. Bob Goodlatte, who served as chairman of the House Judiciary Committee at the time of McCabe’s December 21, 2017 testimony, read aloud Comey’s email. A transcript of the testimony was released three weeks ago by House Judiciary Committee Ranking Member Doug Collins, R-Ga, although the portion in question did not receive media attention.

Goodlatte read Comey’s email as follows:

The penultimate paragraph of the May 2 draft reads as follows: Accordingly, although the Department of Justice makes final decisions on matters such as this, I am completing the investigation by expressing to Justice my view that no charges are appropriate in this case.

Goodlatte noted that “this paragraph is virtually identical to what Director Comey eventually said more than 2 months later on July 25, 2016, in recommending no charges against Secretary Clinton. It seems to confirm that the FBI, including the Director, had made up its mind not to charge Secretary Clinton before interviewing her.”

McCabe disputed that characterization, retorting, “It may seem that way reading it now. But I know that Director Comey had not made up his mind at that time.”

There is no evidence that Comey tested language to use if charges were to be filed against Clinton. Indeed, McCabe admitted as much when he was asked whether Comey similarly prepared a statement recommending charges in the Clinton email case.

McCabe then repeatedly stated that he is not aware of any other precedent similar to Comey’s draft statement against recommending charges two months before Clinton was interviewed.

McCabe did so in the following exchanges with North Carolina Rep. Mark Meadows:

Meadows. So is this common practice, in normal investigations of every type, to do a memo 2 months ahead of time to lay out what you’re going to say with a conclusion? So let’s take it outside of this particular person. How many other times does that happen?

Mr. McCabe. No, sir, it’s not common.

Mr. Meadows. So this is a unique situation where he did it this one time?

Mr. McCabe. This is the only time I am aware of, sir.

…

Mr. Meadows. Is this case so unique that you would have a prepared document 2 months ahead of interviewing the witness? Is that normal protocol within the FBI?

Mr. McCabe. It is not normal protocol within the FBI to release a statement about a case —

Mr. Meadows. That’s not the question I asked, Mr. McCabe.

Mr. McCabe. — we believed we were going to —

Mr. Meadows. Is it normal protocol — is it normal protocol to draft a letter by the FBI 2 months before you interviewed the witness to draw a conclusion? Is that normal protocol?

Mr. McCabe. I have not seen that before, sir.

Mr. Meadows. So your answer is no, it’s not normal protocol?

Mr. McCabe. I’m not aware of that protocol. I’ve never seen that. I haven’t been through an experience like this in the pendency of my career. So, no, I’ve never seen that before.

Mr. Meadows. I yield back.

McCabe’s statements on the matter may take on renewed significance after the release of FBI emails last week showing, among other things, that Comey’s agency in 2016 sought to “expeditiously” accommodate a request for information from Clinton’s lawyer. Judicial Watch obtained and released the emails between controversial former FBI officials Peter Strzok and Lisa Page.

“These incredible documents show the leadership of the FBI rushed to give Hillary Clinton her FBI interview report shortly before the election,” Judicial Watch President Tom Fitton charged. “And the documents also show the FBI failed to timely document interviews in the Clinton email ‘matter’ – further confirming the whole investigation was a joke.”
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Louisiana's Musical Legacy Gets a Boost from Foundation

Updated Category News Views 201

Preserving the Tunes of the Bayou Well, if that ain't music to your ears! The Louisiana First Horizon Foundation is sliding into the spotlight with news that's bound to strike a chord with any lover of the state's iconic rhythms. They're diving in deep, backing the Louisiana Music Museum right in the heart of Lafayette. Now, that ain't just another charity stunt; it's a...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 151

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
Future FinTech Under Investigation: Shareholder Impact Looms

Updated Category News Views 81

Future FinTech Faces Legal Scrutiny When the walls close in under financial suspicion, the spotlight can burn brighter than any anticipated market gain. That's precisely what Future FinTech Group Inc. (NasdaqCM: FTFT) is up against now. Kahn Swick & Foti, LLC, featuring the ex-Attorney General of Louisiana, Charles C. Foti, Jr., has begun scrutinizing the actions of...

Continue Reading
AXON Revenue Forecast Cut Spurs Legal Investigation

Updated Category News Views 135

Axon's Revenue Forecast Takes a Hit Listen up, folks. Axon Enterprise, Inc. (NASDAQ: AXON) has stirred the pot, cutting their 2026 revenue forecast faster than you can say "counter-drone deployment." Back in August, they were riding high on their second-quarter call, raising their growth forecast to a cheerful 32%-34%. Fast forward to November, and it's been slashed to...

Continue Reading
Cultural Bridges and Mazu's Spirit: Gen Z's Role

Updated Category News Views 138

Youthful Energy Revives Ancient Traditions Over in Putian, China, you'd have seen a curious sight in late October—hundreds of young folks from over 20 corners of the globe gathering not for a concert or some influencer meet-up, but to dive into Mazu's legacy. This ain't your typical cultural event. More than 200 Gen Z representatives came together, bridging their...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 73

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading
CleanSpark Sets Investor Events with Promising Outlook

Updated Category News Views 184

CleanSpark's Strategy Gets the Spotlight Looks like CleanSpark's stepping up to the plate, folks. They're shouting from the rooftops about hitting the upcoming investor events, and it’s no small potatoes. The company’s lined up a string of high-profile conferences, showcasing their ambition to stay ahead in the energy and data center games. We're talking about the...

Continue Reading
Century Lithium's 2026 AGM Time Clarification Issued

Updated Category News Views 129

Time Zone Confusion No More Ah, time zones. They just keep finding ways to trip up the folks at Century Lithium. The company’s got itself in a twist over when the Annual General Meeting's supposed to kick off. Turns out, they've clarified the timing for their 2026 AGM—it’s stamped for 10:00 a.m. Pacific Time. British Columbia’s ditched the seasonal time change, so...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 77

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
AZZ Inc.'s 2026 Sustainability Report: A Closer Look

Updated Category News Views 231

Diving into AZZ's Sustainability Commitment AZZ Inc., known in the trading circles as NYSE:AZZ, has just dropped its 2026 Sustainability Report and it’s quite the document to chew on. This ain't your typical corporate fluff. Tom Ferguson, the man steering the AZZ ship, laid it down plain and simple. This report isn’t just about ticking boxes for ESG; it’s reflecting...

Continue Reading

Top 5 Most Recently Viewed Articles

ImmunityBio Advances Towards EU Approval for Cancer Treatment

Updated Category News Views 95

ImmunityBio's Journey Towards EU Approval The European Medicines Agency (EMA) has made a significant recommendation toward approving ImmunityBio, Inc.’s Anktiva (nogapendekin alfa inbakicept), intended for use alongside Bacillus Calmette-Guérin (BCG) for treating BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). Clinical Trial Results and Findings This...

Continue Reading
Temperature Monitoring Systems Set to Reach $5.66 Billion by 2030

Updated Category News Views 139

Temperature Monitoring Systems Market Analysis and Growth Projections The temperature monitoring systems market, valued at USD 3.80 billion recently, is on a promising trajectory. It is expected to expand at a compound annual growth rate (CAGR) of 5.3%, reaching an impressive USD 5.66 billion by 2030. This growth can be attributed to several factors, including...

Continue Reading
Comparative Insights on Apple and Its Competitors' Performance

Updated Category News Views 336

Performance Insights into Apple and Industry Competitors In the ever-evolving realm of technology, understanding the dynamics of company performance is vital for investors and analysts. This analysis focuses on Apple Inc. (NASDAQ: AAPL) and its key competitors in the Technology Hardware, Storage & Peripherals sector. We'll delve into essential financial metrics, market...

Continue Reading
X Financial Achieves Impressive Growth in Recent Earnings

Updated Category News Views 108

X Financial Reveals Strong Q2 Performance X Financial (NYSE: XYF), a prominent player in the fintech industry, has reported robust financial results that highlight its significant growth and commitment to enhancing its service offering. The company recently disclosed its unaudited financial results for the second quarter, and the figures are quite remarkable. Q2 2025...

Continue Reading
Tyra Biosciences to Engage Investors at Major Conferences

Updated Category News Views 290

Tyra Biosciences to Engage Investors at Major Conferences Tyra Biosciences, Inc. (Nasdaq: TYRA) is a pioneering biotechnology company dedicated to crafting next-generation precision medicines with a keen focus on Fibroblast Growth Factor Receptor (FGFR) biology. The company has great momentum as it takes strides in engaging with investors at a series of crucial investor...

Continue Reading